Related Experiment Video
Updated: May 19, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
Published on: January 7, 2019
Stem cell transplantation in cardiovascular disease: an update
1Institute of Burn Research, Southwest Hospital, Third Military Medical University, Chongqing, China.
Insights
Stem cell therapy shows promise for cardiovascular diseases, but optimal treatment strategies require further research. This review examines clinical findings and delivery challenges for effective stem cell application.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Cell Therapy
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of death.
- Novel therapeutic strategies are being developed, including stem cell transplantation.
- Early clinical trials suggest safety and potential, but key parameters are undefined.
Purpose of the Study:
- To review clinical studies on stem cell therapy for cardiovascular diseases.
- To discuss challenges in delivering stem cell therapy for CVDs.
- To identify areas needing further research for optimal stem cell application.
Main Methods:
- Systematic review of phase 1 and 2 clinical trials.
- Analysis of data on cell types, infusion timing, dosage, and administration routes.
- Discussion of current challenges and future directions in stem cell delivery.
Main Results:
- Stem cell transplantation has demonstrated safety and feasibility in preliminary trials.
- Optimal cell types, timing, dosage, and routes for stem cell therapy remain undetermined.
- Significant challenges exist in the effective delivery of stem cells to target cardiovascular tissues.
Conclusions:
- Stem cell therapy holds potential for treating cardiovascular diseases.
- Further research is essential to optimize stem cell therapy protocols.
- Overcoming delivery challenges is critical for successful clinical translation of stem cell therapy for CVDs.
Abstract:
Despite the development of novel therapeutic strategies, cardiovascular diseases remain the main cause of morbidity and mortality worldwide. Many phase 1 and 2 clinical trials have reported the safety, feasibility and promising potential of stem cell transplantation, however, the optimal cell types, timing of infusion, cell dosage and routes of administration remain to be determined. This paper reviews the findings of various clinical studies and discusses the challenges facing the delivery of stem cell therapy in cardiovascular diseases.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cardiomyopathy V: Interprofessional Care
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

